Results 181 to 190 of about 49,971 (256)
Mechanistic Investigation of Vitexin in Ameliorating Ovarian Fibrosis in PCOS Mice via the NR4A1/NLRP3 Signaling Pathway. [PDF]
Sun H, Xu J, Pan C, Song JL, Zhou Y.
europepmc +1 more source
ABSTRACT Objective To evaluate the effect of inositol supplementation on biochemical hyperandrogenism in women with polycystic ovary syndrome (PCOS) and to explore whether metabolic phenotype modifies the endocrine response. Design Systematic review and meta‐analysis of randomized controlled trials conducted in accordance with PRISMA guidelines ...
Daniele Tienforti +10 more
wiley +1 more source
ABSTRACT Aims This study aimed to assess the effects of low‐dose tirzepatide combined with metformin (COM) versus metformin (MET) monotherapy in overweight/obese women with polycystic ovary syndrome (PCOS). Materials and Methods Sixty overweight/obese women with PCOS were randomised to the MET group (1000 mg twice daily [BID]) or the COM group (MET ...
Zhuoran Yang +7 more
wiley +1 more source
Androgenetic alopecia in polycystic ovary syndrome: a cutaneous marker of systemic metabo-inflammatory and endocrine dysfunction. [PDF]
Motafeghi F +3 more
europepmc +1 more source
ABSTRACT Aim Despite growing public attention toward infertility treatments and elective oocyte cryopreservation, awareness of fertility among young adults remains limited. Accurate knowledge of age‐related fertility declines and ovarian reserve is particularly lacking in nonmedical populations. Providing accurate knowledge about reproductive health is
Tomomi Seki +10 more
wiley +1 more source
Editorial: Polycystic ovarian syndrome in adolescence. [PDF]
Sharma R.
europepmc +1 more source
ABSTRACT Background In 2023 and 2024, research into semaglutide (SEMA), an antiobesity and antidiabetic medication, indicated potential benefits beyond its approved uses, particularly in preventing Alzheimer's disease (AD). This highlights the link between obesity and AD development.
Amene Saghazadeh +14 more
wiley +1 more source
Androgen profiling in adolescent girls with polycystic ovary syndrome. [PDF]
Zhang X +10 more
europepmc +1 more source
Fibroblast growth factor receptor 1 (FGFR1) is co‐translationally integrated into endoplasmic reticulum (ER) membranes and undergoes N‐glycosylation at several positions. This process is essential for FGFR1 progression through the secretory pathway.
Paulina Działek +5 more
wiley +1 more source
Reduced CAG Repeats in the Androgen Receptor Gene May Independently Cause Polycystic Ovarian Syndrome. [PDF]
Sharma R, Shain DH.
europepmc +1 more source

